Geisler SB - Search Results

1

A mitochondrial target sequence polymorphism in manganese superoxide dismutase predicts inferior survival in breast cancer patients treated with cyclophosphamide.

Glynn SA, Boersma BJ, Howe TM, Edvardsen H, Geisler SB, Goodman JE, Ridnour LA, Lønning PE, Børresen-Dale AL, Naume B, Kristensen VN, Chanock SJ, Wink DA, Ambs S. Glynn SA, et al. Among authors: geisler sb. Clin Cancer Res. 2009 Jun 15;15(12):4165-73. doi: 10.1158/1078-0432.CCR-09-0119. Epub 2009 Jun 9. Clin Cancer Res. 2009. PMID: 19509150 Free PMC article.

2

Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients.

Aas T, Børresen AL, Geisler S, Smith-Sørensen B, Johnsen H, Varhaug JE, Akslen LA, Lønning PE. Aas T, et al. Nat Med. 1996 Jul;2(7):811-4. doi: 10.1038/nm0796-811. Nat Med. 1996. PMID: 8673929

3

Primary systemic treatment with weekly doxorubicin monotherapy in women with locally advanced breast cancer; clinical experience and parameters predicting outcome.

Aas T, Geisler S, Paulsen T, Børresen-Dale AL, Varhaug JE, Lønning PE, Akslen LA. Aas T, et al. Acta Oncol. 1996;35 Suppl 5:5-8. doi: 10.3109/02841869609083960. Acta Oncol. 1996. PMID: 9142957

4

Differential effect of carbamazepine and valproate monotherapy on plasma levels of oestrone sulphate and dehydroepiandrosterone sulphate in male epileptic patients.

Geisler J, Engelsen BA, Berntsen H, Geisler S, Lønning PE. Geisler J, et al. J Endocrinol. 1997 May;153(2):307-12. doi: 10.1677/joe.0.1530307. J Endocrinol. 1997. PMID: 9166121

5

Absence of p21 expression is associated with abnormal p53 in human breast carcinomas.

Ellis PA, Lonning PE, Borresen-Dale A, Aas T, Geisler S, Akslen LA, Salter I, Smith IE, Dowsett M. Ellis PA, et al. Br J Cancer. 1997;76(4):480-5. doi: 10.1038/bjc.1997.413. Br J Cancer. 1997. PMID: 9275025 Free PMC article.

6

Changes in folate status as determined by reduction in total plasma homocysteine levels during leucovorin modulation of 5-fluorouracil therapy in cancer patients.

Geisler J, Geisler SB, Lønning PE, Smaaland R, Tveit KM, Refsum H, Ueland PM. Geisler J, et al. Among authors: geisler sb. Clin Cancer Res. 1998 Sep;4(9):2125-8. Clin Cancer Res. 1998. PMID: 9748129 Clinical Trial.

7

Effects of treatment with megestrol acetate on the insulin-like growth factor system: time and dose dependency.

Helle SI, Lundgren S, Geisler S, Ekse D, Holly JM, Lønning PE. Helle SI, et al. Eur J Cancer. 1999 Jul;35(7):1070-5. doi: 10.1016/s0959-8049(99)00055-6. Eur J Cancer. 1999. PMID: 10533450

8

Influence of TP53 gene alterations and c-erbB-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer.

Geisler S, Lønning PE, Aas T, Johnsen H, Fluge O, Haugen DF, Lillehaug JR, Akslen LA, Børresen-Dale AL. Geisler S, et al. Cancer Res. 2001 Mar 15;61(6):2505-12. Cancer Res. 2001. PMID: 11289122 Clinical Trial.

9

Plasma insulin-like growth factor binding protein-3 proteolysis is increased in primary breast cancer.

Helle SI, Geisler S, Aas T, Paulsen T, Holly JM, Lønning PE. Helle SI, et al. Br J Cancer. 2001 Jul 6;85(1):74-7. doi: 10.1054/bjoc.2001.1860. Br J Cancer. 2001. PMID: 11437405 Free PMC article.

10

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.

Sørlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Lønning PE, Børresen-Dale AL. Sørlie T, et al. Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10869-74. doi: 10.1073/pnas.191367098. Proc Natl Acad Sci U S A. 2001. PMID: 11553815 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

37 results

Search Page